Introduction {#H1-1-ZOI200006}
============

Although sepsis is common, reductions in hospital mortality have led to an increasing number of survivors,^[@zoi200006r1],[@zoi200006r2]^ with more than 1 million patients being discharged after treatment of sepsis from United States hospitals each year.^[@zoi200006r3]^ However, sepsis survivorship often comes at a cost, namely reduced health-related quality of life, cognitive and functional impairments,^[@zoi200006r4]^ increased risks of hospital readmission,^[@zoi200006r5],[@zoi200006r6],[@zoi200006r7]^ and long-term mortality risk.^[@zoi200006r8],[@zoi200006r9],[@zoi200006r10],[@zoi200006r11]^ Amid a heightened awareness of these long-term consequences,^[@zoi200006r12],[@zoi200006r13]^ improving the quality of post-sepsis care has become a global priority.^[@zoi200006r13]^

Efforts to improve outcomes among sepsis survivors have largely focused on preventing or mitigating postdischarge morbidity and mortality. Nearly 1 in 2 sepsis survivors receive postacute care services, such as home health care, inpatient rehabilitation, and skilled nursing facility placement.^[@zoi200006r5],[@zoi200006r14],[@zoi200006r15]^ Yet, the long-term risk of death after sepsis remains high compared with hospitalized patients without sepsis.^[@zoi200006r7],[@zoi200006r9],[@zoi200006r16]^ Despite mounting evidence that sepsis survivorship is associated with increased mortality, little attention has been paid to the patterns of end-of-life care among this population. This is a particularly important evidence gap to fill in sepsis research considering the sustained national focus on improving the quality of end-of-life care for all seriously ill adults.^[@zoi200006r17],[@zoi200006r18]^ Furthermore, as policy recommendations regarding optimal advance care planning practice and use of community-based palliative care services continue to evolve,^[@zoi200006r19],[@zoi200006r20],[@zoi200006r21],[@zoi200006r22]^ it is important for sepsis survivors to be recognized as a potential population in need of these services.

In this national study, we assessed the risk of long-term mortality and end-of-life care among Medicare beneficiaries discharged to home health care after sepsis. Homes are common postacute care destinations after sepsis, second only to skilled care facilities.^[@zoi200006r5],[@zoi200006r14],[@zoi200006r15]^ Annually, approximately 200 000 sepsis survivors are discharged to home to receive health care services such as skilled nursing, physical and occupational therapy, and health aid visits.^[@zoi200006r15]^ Because home health care spending is projected to outpace any other national health expenditure over the next decade,^[@zoi200006r14]^ it is essential to evaluate outcomes among this population. In the present study, 1-year mortality rates were assessed and factors associated with mortality were identified from the sepsis hospitalization and the initial home health assessment, including functional assessments. The rates of hospitalization among the decedents in the last 30 days of life, in-hospital death, and hospice use, were assessed and characteristics associated with hospice use were identified.

Methods {#H1-2-ZOI200006}
=======

Data Sources and Study Population {#H2-1-ZOI200006}
---------------------------------

This retrospective cohort study used Medicare administrative and claims files from calendar years 2013 and 2014 to identify patients with sepsis who were hospitalized and discharged to home health care between July 1, 2013, and December 31, 2013, and to evaluate hospice and mortality outcomes up to 1 year after hospital discharge. The files used included the Medicare Beneficiary Summary file, Medicare Inpatient Standard Analytic File (SAF), Outpatient SAF, Home Health SAF, Hospice SAF, Part B SAF, Chronic Conditions Warehouse (CCW), and US Census data.^[@zoi200006r52]^ We linked these files with the Outcome and Assessment Information Set (OASIS)--C,^[@zoi200006r23],[@zoi200006r24]^ a comprehensive, federally mandated assessment of patients' health, social, cognitive, and functional status, which is completed on initiation of home health care services. This study was approved by the respective institutional review boards of the Visiting Nurse Service of New York and the University of Pennsylvania, with a waiver of informed consent under category 4 of the Federal Policy for the Protection of Human Subjects (45 CFR 46) in 2015. This report followed the Strengthening the Reporting of Observational Studies in Epidemiology ([STROBE](https://www.equator-network.org/reporting-guidelines/strobe/)) reporting guideline.^[@zoi200006r25]^ Initial and final primary analyses were conducted in July 2017 and July and August 2019, respectively.

Sepsis was defined using a combination of 2 strategies given the limited sensitivity of sepsis identification from administrative claims.^[@zoi200006r26]^ First, we used the *International Classification of Diseases and Related Health Problems, Ninth Revision, Clinical Modification (ICD-9-CM)* codes 995.91 (sepsis without organ dysfunction), 995.92 (severe sepsis), and 785.52 (septic shock), which were added to the *ICD-9-CM* codes in 2003 to improve accuracy of case identification.^[@zoi200006r26]^ Second, we used the implicit approach developed by Angus and colleagues^[@zoi200006r27]^ that requires an ICD-9-CM code for infection and end-organ dysfunction, which was initially developed using 1995 claims data and was subsequently validated using administrative claims from 2009 to 2010^[@zoi200006r28]^ and medical records from 2005 to 2009.^[@zoi200006r26]^

Beneficiaries had to be at least 18 years of age and have received at least 1 home health care visit within 1 week of discharge. Beneficiaries with additional health care use (hospital readmission, observation unit stay, and hospice admission) before their first home health visit and those without complete OASIS-C data were excluded from the study. Finally, we included only the index sepsis discharge to home health care in this sample to ensure independence of observations.

Outcomes {#H2-2-ZOI200006}
--------

The 1-year mortality among all sepsis survivors and hospice use among decedents were examined. The date of death was obtained from Medicare records and time to death was calculated from the discharge date of index hospital stay. The Inpatient SAF was used to identify hospitalization and intensive care unit (ICU) use within the last 30 days of life and acute care hospital as site of death. Hospice enrollment and length of stay were identified using the Hospice SAF, with late hospice referral defined as a hospice admission date 7 or fewer days prior to the date of death.^[@zoi200006r29],[@zoi200006r30],[@zoi200006r31]^

Individual Characteristics {#H2-3-ZOI200006}
--------------------------

Medicare administrative data provided patients' demographic characteristics, comorbidities, and clinical characteristics from the index sepsis discharge, including the admission type (Medicare Severity--Diagnosis Related Group \[MS-DRG\]), ICU use, and infection source. To address underreporting in claims data, ethnicity and median family income in the county where the patient lived were obtained from OASIS-C and census data, respectively, and a diagnosis of Alzheimer disease and associated dementias was obtained from the CCW.

The initial OASIS-C assessment was conducted by a trained home health clinician at the start of a new episode of home health care within 2 days of hospital discharge for 81% of the cohort (n = 70 941) and within 7 days for the remaining sample (n = 16 640). More than 100 items were assessed, including activities of daily living (ADLs), instrumental activities of daily living (IADLs), living arrangements, cognitive functioning, sensory and behavioral status, disease signs and symptoms by organ system, frailty, and overall health status.^[@zoi200006r32],[@zoi200006r33]^

Statistical Analyses {#H2-4-ZOI200006}
--------------------

Variables were summarized using frequencies and proportions for categorical data or means (SDs) and medians (interquartile ranges \[IQRs\]) for continuous data. Bivariate analyses were performed using a χ^2^ test to compare patient characteristics between decedents and survivors. Survival data were expressed as medians (IQRs), and analyses were performed using the Kaplan-Meier method, with censoring of all patients who remained alive 365 days after sepsis discharge.

Two multivariate logistic regression models were built using forward selection to examine the independent associations between patient characteristics and 1-year mortality among all sepsis survivors and hospice use among the decedents. Candidate covariates were selected a priori based on existing literature and clinical expertise and included those variables with a 2-sided *P* \< .05 in the final multivariate models. Variance inflation factor diagnostic tests were used to check for collinearity between covariates and those with a value greater than 10 were excluded from the final models.^[@zoi200006r34]^ Both final models included the following characteristics known before and during the index sepsis hospitalization: age, race/ethnicity, Medicaid status, comorbidities,^[@zoi200006r35]^ sepsis severity, hospital-acquired sepsis, infection source, ICU admission, and surgical admission type. Items from the postdischarge OASIS-C home health assessment included in the final models are provided in [Table 1](#zoi200006t1){ref-type="table"} and include the following: risk for hospitalization, overall health status, living arrangement, impaired vision, number of medications, dyspnea, cognitive impairment, and the number of ADL or IADL dependencies. Categorical variables were collapsed in the final models based on the distribution of responses. Data completeness was excellent; 168 patients (1.9%) with an unknown or unclear or missing response for the overall status item on the home health assessment were excluded from the models.

###### Characteristics of 87 581 Patients in the Medicare Sepsis Survivor Cohort Discharged to Home Health Care

  Characteristic[^a^](#zoi200006t1n1){ref-type="table-fn"}                                                   No. (%) of Patients
  ---------------------------------------------------------------------------------------------------------- ---------------------
  Age, y                                                                                                     
  \<65[^b^](#zoi200006t1n2){ref-type="table-fn"}                                                             14 236 (16.3)
  65-74                                                                                                      24 022 (27.4)
  75-84                                                                                                      28 067 (32.0)
  ≥85                                                                                                        21 256 (24.3)
  Race                                                                                                       
  Black                                                                                                      10 744 (12.3)
  Non-Hispanic white                                                                                         69 499 (79.4)
  Hispanic                                                                                                   4773 (5.5)
  Other[^c^](#zoi200006t1n3){ref-type="table-fn"}                                                            2565 (2.9)
  Sex                                                                                                        
  Female                                                                                                     48 472 (55.3)
  Male                                                                                                       39 109 (44.7)
  Medicaid eligible                                                                                          23 381 (26.7)
  Annual family income, \$, mean (SD)                                                                        54 100 (14 810)
  Comorbidities                                                                                              
  Hypertension                                                                                               60 474 (69.0)
  Fluid and electrolyte disorders                                                                            48 439 (55.3)
  Deficiency anemias                                                                                         31 687 (36.2)
  Renal failure                                                                                              29 802 (34.0)
  Alzheimer disease and related disorders                                                                    28 095 (32.1)
  Chronic pulmonary disease                                                                                  28 153 (32.1)
  Congestive heart failure                                                                                   21 479 (24.5)
  Diabetes without chronic complications                                                                     24 943 (28.5)
  Metastatic cancer, lymphoma, or solid tumor without metastasis[^d^](#zoi200006t1n4){ref-type="table-fn"}   11 427 (13.0)
  Hypothyroidism                                                                                             17 340 (19.8)
  Coagulopathy                                                                                               13 534 (15.5)
  Weight loss                                                                                                9693 (11.1)
  Other neurological disorders                                                                               11 958 (13.7)
  Peripheral vascular disease                                                                                10 469 (12.0)
  Depression                                                                                                 11 950 (13.6)
  Obesity                                                                                                    13 171 (15.0)
  Diabetes with chronic complications                                                                        9672 (11.0)
  Total No. of comorbidities, mean (SD)                                                                      4.35 (1.89)
  Infection source                                                                                           
  Kidney, urinary tract, and other genitourinary                                                             36 202 (41.3)
  Pneumonia and other respiratory                                                                            30 666 (35.0)
  Bone, joint, and skin/soft tissue                                                                          13 458 (15.4)
  Gastrointestinal                                                                                           8721 (9.96)
  Device related                                                                                             3264 (3.73)
  Bacteremia                                                                                                 1992 (2.27)
  Cardiovascular/endocarditis                                                                                1263 (1.44)
  Postoperative                                                                                              1905 (2.18)
  Central nervous system                                                                                     331 (0.38)
  Other or unknown                                                                                           24 959 (28.5)
  Sepsis severity                                                                                            
  Sepsis                                                                                                     11 934 (13.6)
  Severe sepsis                                                                                              70 513 (80.5)
  Septic shock                                                                                               5134 (5.86)
  Intensive or cardiac care unit admission                                                                   44 241 (50.5)
  Medical admission type                                                                                     70 135 (80.1)
  Home health assessment                                                                                     
  Indicators for risk of hospitalization[^b^](#zoi200006t1n2){ref-type="table-fn"}                           
  Decline in mental, emotional, behavioral condition                                                         13 425 (15.3)
  Multiple hospitalizations (≥2 in past 12 mo)                                                               43 993 (50.2)
  Frailty indicators (weight loss, self-reported exhaustion)                                                 36 127 (41.2)
  Assessment of overall health status                                                                        
  Stable, no risks of complications or death                                                                 4248 (4.9)
  Temporarily high risks but likely to return to stable condition                                            42 081 (48.0)
  Fragile health/ongoing risks of complications/death                                                        33 950 (38.8)
  Serious progressive conditions that could lead to death within 1 y                                         7134 (8.2)
  Unknown or missing                                                                                         168 (0.2)
  Vision                                                                                                     
  Normal                                                                                                     17 529 (71.6)
  Partially impaired                                                                                         6297 (25.7)
  Severely impaired                                                                                          652 (2.7)
  Speech and oral expression                                                                                 
  Expresses complex ideas/feelings/needs with no impairment                                                  50 830 (58.0)
  Minimal difficulty in expressing ideas and needs                                                           26 481 (30.2)
  Expresses simple ideas/needs with moderate difficulty                                                      6163 (7.0)
  Severe difficulty expressing simple ideas/needs                                                            2326 (2.7)
  Unable to express basic needs but not comatose or unresponsive                                             1045 (1.2)
  Patient nonresponsive or unable to speak                                                                   736 (0.8)
  Frequency of pain interfering with activity                                                                
  No pain                                                                                                    23 107 (26.4)
  Pain that does not interfere with activity or movement                                                     7814 (8.9)
  Less often than daily                                                                                      10 148 (11.6)
  Daily, but not constantly                                                                                  35 611 (40.7)
  All the time                                                                                               10 901 (12.4)
  Living arrangements                                                                                        
  Lives alone                                                                                                16 404 (18.7)
  Lives with someone                                                                                         66 098 (75.5)
  Lives in congregate (eg, assisted living)                                                                  5079 (5.8)
  Presence of dyspnea                                                                                        
  Not short of breath                                                                                        19 056 (21.8)
  Walking \>20 ft, climbing stairs                                                                           18 467 (21.1)
  With moderate exertion                                                                                     28 987 (33.1)
  With minimal exertion                                                                                      16 193 (18.5)
  At rest (during day or night)                                                                              4878 (5.6)
  Respiratory treatments needed                                                                              23 791 (27.2)
  Cognitive function                                                                                         
  Alert and/or oriented                                                                                      46 049 (52.6)
  Requires prompting                                                                                         27 893 (31.8)
  Requires assistance or direction                                                                           8974 (10.2)
  Requires considerable assistance or direction                                                              3422 (3.9)
  Totally dependent                                                                                          1243 (1.4)
  No. of ADL or IADL dependencies                                                                            
  0-2                                                                                                        10 710 (12.2)
  3-5                                                                                                        22 317 (25.5)
  6-8                                                                                                        22 501 (25.7)
  9-11                                                                                                       24 492 (28.0)
  12-13                                                                                                      7561 (8.6)

Abbreviations: ADL, activities of daily living; IADL, instrumental ADLs.

Percentages in each category may not add up to 100 owing to rounding.

Of the 14 236 Medicare beneficiaries aged younger than 65 years, 12 145 (85.3%) received disability insurance benefits, 600 (4.2%) received end-stage renal disease benefits, and 1458 (10.2%) received disability and end-stage renal disease benefits.

Other includes mixed race/ethnicity or not stated.

Includes patients with cancer diagnoses present within the 6 months prior to sepsis discharge date.

In secondary analyses, we included only covariates with a bivariate association of *P* \< .001 to avoid overfitting the models. The results of these parsimonious models remained unchanged; thus, the results of the full explanatory models are presented. Analyses stratified by the presence of a cancer diagnosis, which has previously been shown to be associated with in-hospital mortality and hospice referral among sepsis readmissions, were also performed.^[@zoi200006r8]^

For all analyses, given the large sample size, statistical testing was 2-sided with a significance threshold of *P* \< .001, and results were preferentially judged by their clinical relevance. RStudio, version 3.3.1 (R Core Team), was used for descriptive statistics and statistical analyses. SAS, version 9.4 (SAS Institute Inc) was used for diagnostic variance inflation factor tests and Kaplan-Meier plot generation.

Results {#H1-3-ZOI200006}
=======

The cohort included 87 581 sepsis survivors with Medicare insurance who were discharged to new home health care services between July 1, 2013, and December 31, 2013 ([Figure 1](#zoi200006f1){ref-type="fig"}). Among them, 49 323 (56.3%) patients were aged 75 years or older, 69 499 (79.4%) were non-Hispanic white, and 48 472 (55.3%) were women. Overall, patients had a mean (SD) total number of comorbidities of 4.35 (1.89), and 64 200 (73.3%) were not Medicaid-eligible ([Table 1](#zoi200006t1){ref-type="table"}). Severe sepsis was observed in most cases (70 513 \[80.5%\]), with the genitourinary system being the most common infection source (36 202 \[41.3%\]), and only half of the patients (44 241 \[50.5%\]) having received care in an ICU during the index sepsis hospitalization. Home health care assessments after discharge suggested that half of the patients had at least 1 indicator of risk for hospitalization (43 993 \[50.2%\]) and dependency in more than 2 ADLs/IADLs (76 871 \[87.8%\]). Uncontrolled symptoms were common, with 46 512 (51.3%) of patients experiencing pain daily or constantly and 68 525 (78.3%) having dyspnea on exertion or at rest. Nearly half of the patients had at least mild limitations in cognitive function (41 532 \[47.3%\]) and speech (36 751 \[41.9%\]).

![Flow Diagram for Identification of Cohort of Medicare Sepsis Survivors Discharged to Home Health Care](jamanetwopen-3-e200038-g001){#zoi200006f1}

Nursing visits, which were received by 83 537 \[95.4%\] patients, were the most common home health care service provided within 7 days of sepsis discharge, followed by physical therapy (46 096 \[52.6%\]), occupational therapy (14 114 \[16.1%\]), and speech therapy (1897 \[2.2%\]). During the first week, 34 064 (38.9%) sepsis survivors were seen in the ambulatory setting by a medical professional.

Mortality and End-of-Life Health Care Use {#H2-5-ZOI200006}
-----------------------------------------

Among the total survivors, 24 423 (27.9%) patients died within 1 year of discharge, with a median (IQR) survival time of 119 (51-220) days ([Figure 2](#zoi200006f2){ref-type="fig"}). The characteristics of decedents and survivors at 1 year after discharge differed in several patient-related, sepsis-related, and home health assessment characteristics (eTables 1 and 2 in the [Supplement](#note-ZOI200006-1-s){ref-type="supplementary-material"}), most notably in the proportion of patients with a cancer diagnosis (decedents, 5965 \[24.4%\] vs survivors, 5462 \[8.2%\]; *P* \< .001). Among all decedents, 16 684 (68.2%) were hospitalized, 10 190 (61.1%) were admitted to an ICU during the last 30 days of life, and 6560 (26.8%) died in an acute care hospital ([Table 2](#zoi200006t2){ref-type="table"}). In total, 12 573 (51.4%) decedents were enrolled in hospice prior to death, with a median (IQR) time from sepsis discharge to hospice enrollment of 100 (36-199) days. The median (IQR) hospice length of stay was 10 (3-33) days, with 5729 (45.6%) of those enrolled receiving hospice services for 7 or fewer days prior to death.

![One-Year Survival Among 87 581 Patients After Sepsis Discharge to Home Health Care](jamanetwopen-3-e200038-g002){#zoi200006f2}

###### Acute Care and Hospice Use Among 24 423 Decedents

  Acute Care in Last 30 d of Life                          No. (%) of Patients
  -------------------------------------------------------- ---------------------
  Hospitalization                                          16 684 (68.2)
  Intensive/cardiac care unit admission                    10 190 (61.1)
  Death in acute care hospital                             6560 (26.8)
  Hospice                                                  
  Any hospice use                                          12 573 (51.4)
  Days to enrollment from sepsis discharge, median (IQR)   100 (36-199)
  Length of stay, median (IQR), d                          10 (3-33)
  Use ≤7 d                                                 5729 (45.6)

Abbreviation: IQR, interquartile range.

Factors Independently Associated With Risk of 1-Year Mortality {#H2-6-ZOI200006}
--------------------------------------------------------------

In multivariate analyses, several factors were found to be independently associated with an increased risk of 1-year mortality ([Table 3](#zoi200006t3){ref-type="table"}). Patient-level risk factors included older age (≥85 years, OR, 1.47; 95% CI, 1.40-1.54; *P* \< .001) and the presence of comorbid conditions in general and cancer diagnosis in particular (OR, 3.66; 95% CI, 3.50-3.83; *P* \< .001). Sepsis-related factors known at the time of discharge that were independently associated with an increased risk of 1-year mortality included severe sepsis (OR, 1.30; 95% CI, 1.23-1.37; *P* \< .001), pneumonia and other respiratory infection source (OR, 1.14; 95% CI, 1.09-1.18; *P* \< .001), and ICU use (OR, 1.07; 95% CI, 1.03-1.11; *P* \< .001). Characteristics that appeared to be protective against mortality within the year after sepsis were age younger than 65 years, female sex, obesity, hypertension, and postoperative infection, or a surgical admission during the index sepsis admission.

###### Multivariate Regression Results for 1-Year Mortality Among All Sepsis Survivors and Hospice Enrollment Among Decedents

  Characteristic                                                                  Death Within 1 y of Sepsis Discharge, OR (95% CI) (n = 87 413)   *P* Value   Hospice Enrollment Among Decedents, OR (95% CI) (n = 24 423)   *P* Value
  ------------------------------------------------------------------------------- ---------------------------------------------------------------- ----------- -------------------------------------------------------------- -----------
  **Demographic**                                                                                                                                                                                                             
  Age, y                                                                                                                                                                                                                      
  65-74                                                                           1 \[Reference\]                                                              1 \[Reference\]                                                
  \<65                                                                            0.84 (0.79-0.89)                                                 \<.001      0.76 (0.69-0.84)                                               \<.001
  75-84                                                                           1.08 (1.03-1.13)                                                 \<.001      1.23 (1.14-1.32)                                               \<.001
  ≥85                                                                             1.47 (1.40-1.54)                                                 \<.001      1.49 (1.37-1.61)                                               \<.001
  Race/ethnicity                                                                                                                                                                                                              
  Non-Hispanic white                                                              1 \[Reference\]                                                              1 \[Reference\]                                                
  Black                                                                           1.04 (0.98-1.09)                                                 .12         0.67 (0.61-0.73)                                               \<.001
  Hispanic                                                                        0.91 (0.84-0.98)                                                 .01         0.81 (0.71-0.92)                                               .001
  Other                                                                           0.84 (0.76-0.92)                                                 \<.001      0.64 (0.54-0.76)                                               \<.001
  Sex                                                                                                                                                                                                                         
  Female                                                                          0.85 (0.82-0.87)                                                 \<.001      1.11 (1.05-1.17)                                               \<.001
  Medicaid eligible                                                               0.94 (0.90-0.98)                                                 .005        0.77 (0.72-0.82)                                               \<.001
  **Comorbidities**                                                                                                                                                                                                           
  Metastatic cancer, lymphoma, solid tumor without metastasis                     3.66 (3.50-3.83)                                                 \<.001      2.25 (2.11-2.41)                                               \<.001
  Hypertension                                                                    0.87 (0.84-0.90)                                                 \<.001      0.95 (0.89-1.00)                                               .06
  Fluid and electrolyte disorders                                                 1.03 (1.00-1.07)                                                 .05         0.99 (0.94-1.05)                                               .76
  Deficiency anemias                                                              1.18 (1.14-1.22)                                                 \<.001      1.02 (0.97-1.08)                                               .48
  Renal failure                                                                   1.37 (1.32-1.42)                                                 \<.001      0.94 (0.88-0.99)                                               .02
  Chronic pulmonary disease                                                       1.18 (1.14-1.23)                                                 \<.001      0.89 (0.84-0.95)                                               \<.001
  Diabetes                                                                        0.99 (0.96-1.03)                                                 .63         0.90 (0.85-0.96)                                               \<.001
  Congestive heart failure                                                        1.35 (1.30-1.40)                                                 \<.001      0.85 (0.80-0.90)                                               \<.001
  Obesity                                                                         0.76 (0.69-0.76)                                                 \<.001      0.84 (0.76-0.92)                                               \<.001
  Depression                                                                      0.93 (0.89-0.98)                                                 .003        1.13 (1.04-1.23)                                               .003
  Peripheral vascular disease                                                     1.20 (1.14-1.26)                                                 \<.001      0.84 (0.77-0.91)                                               \<.001
  Weight loss                                                                     1.50 (1.43-1.58)                                                 \<.001      1.06 (0.98-1.14)                                               .15
  Alzheimer disease and associated disorders                                      1.13 (1.09-1.18)                                                 \<.001      1.09 (1.02-1.16)                                               .009
  **Index Sepsis Discharge**                                                                                                                                                                                                  
  Sepsis infection source                                                                                                                                                                                                     
  Bone/joint/skin/tissue                                                          1.03 (0.98-1.08)                                                 .30         0.78 (0.72-0.85)                                               \<.001
  Central nervous system                                                          0.71 (0.51-0.97)                                                 .03         0.75 (0.41-1.35)                                               .33
  Pneumonia and other respiratory                                                 1.14 (1.09-1.18)                                                 \<.001      0.94 (0.89-1.00)                                               .04
  Postoperative                                                                   0.58 (0.51-0.67)                                                 \<.001      1.02 (0.79-1.31)                                               .89
  Sepsis severity                                                                                                                                                                                                             
  Sepsis                                                                          1 \[Reference\]                                                              1 \[Reference\]                                                
  Severe sepsis                                                                   1.30 (1.23-1.37)                                                 \<.001      1.04 (0.96-1.14)                                               .35
  Septic shock                                                                    1.14 (1.05-1.24)                                                 .003        0.88 (0.76-1.01)                                               .06
  Intensive or cardiac care unit admission                                        1.07 (1.03-1.11)                                                 \<.001      0.91 (0.86-0.96)                                               \<.001
  Surgical admission type                                                         0.70 (0.67-0.73)                                                 \<.001      0.90 (0.83-0.98)                                               .01
  **Home Health Assessment Within 7 d of Sepsis Discharge**                                                                                                                                                                   
  Indicators for risk of hospitalization on home health assessment                                                                                                                                                            
  No risks                                                                        1 \[Reference\]                                                              1 \[Reference\]                                                
  Decline in mental, emotional, or behavioral condition                           0.99 (0.95-1.04)                                                 .63         1.05 (0.98-1.13)                                               .18
  Multiple hospitalizations (≥2 in past 12 mo)                                    1.21 (1.17-1.26)                                                 \<.001      1.01 (0.96-1.07)                                               .75
  Frailty indicators (weight loss, self-reported exhaustion)                      1.07 (1.03-1.11)                                                 \<.001      1.04 (0.98-1.10)                                               .19
  Assessment of overall health status[^a^](#zoi200006t3n1){ref-type="table-fn"}                                                                                                                                               
  No risk                                                                         1 \[Reference\]                                                              1 \[Reference\]                                                
  Temporarily high risks but likely to return to stable condition                 0.96 (0.88-1.04)                                                 .35         1.02 (0.88-1.19)                                               .76
  Fragile health/ongoing risks of complications or death                          1.39 (1.27-1.51)                                                 \<.001      1.23 (1.06-1.43)                                               .008
  Serious progressive conditions that could lead to death within 1 y              2.21 (2.01-2.44)                                                 \<.001      1.40 (1.19-1.65)                                               \<.001
  Vision                                                                                                                                                                                                                      
  No impairment                                                                   1 \[Reference\]                                                              1 \[Reference\]                                                
  Partially impaired                                                              0.96 (0.93-1.00)                                                 .81         0.98 (0.92-1.05)                                               .57
  Severely impaired                                                               0.97 (0.87-1.08)                                                 .61         1.07 (0.90-1.27)                                               .46
  Speech and oral expression                                                                                                                                                                                                  
  No impairment                                                                   1 \[Reference\]                                                              1 \[Reference\]                                                
  Minimal impairment                                                              1.02 (0.98-1.07)                                                 .34         1.01 (0.94-1.09)                                               .78
  Moderate to severe impairment                                                   1.09 (1.02-1.17)                                                 .01         1.11 (0.99-1.24)                                               .07
  Unable to speak                                                                 1.13 (0.99-1.30)                                                 .07         0.94 (0.76-1.15)                                               .53
  Cognitive function                                                                                                                                                                                                          
  No impairment                                                                   1 \[Reference\]                                                              1 \[Reference\]                                                
  Mild                                                                            0.99 (0.95-1.04)                                                 .78         1.07 (1.00-1.15)                                               .06
  Moderate                                                                        1.15 (1.04-1.26)                                                 .006        1.14 (0.98-1.32)                                               .09
  Severe                                                                          1.08 (0.92-1.27)                                                 .35         0.78 (0.62-0.98)                                               .04
  Living arrangements                                                                                                                                                                                                         
  Lives alone                                                                     1 \[Reference\]                                                              1 \[Reference\]                                                
  Lives with someone                                                              1.07 (1.02-1.12)                                                 .003        1.16 (1.08-1.26)                                               \<.001
  Lives in congregate (eg, assisted living)                                       1.21 (1.12-1.31)                                                 \<.001      1.93 (1.69-2.19)                                               \<.001
  ADL and/or IADL dependencies                                                                                                                                                                                                
  0-2                                                                             1 \[Reference\]                                                              1 \[Reference\]                                                
  3-5                                                                             1.12 (1.05-1.19)                                                 \<.001      1.18 (1.05-1.33)                                               .005
  6-8                                                                             1.34 (1.25-1.43)                                                 \<.001      1.16 (1.04-1.31)                                               .01
  9-11                                                                            1.90 (1.78-2.03)                                                 \<.001      1.22 (1.08-1.37)                                               .001
  12-13                                                                           2.80 (2.57-3.05)                                                 \<.001      1.15 (0.99-1.32)                                               \<.07
  Presence of dyspnea                                                                                                                                                                                                         
  Not short of breath                                                             1 \[Reference\]                                                              1 \[Reference\]                                                
  With moderate exertion/walking \>20 ft, climbing stairs                         1.10 (1.05-1.16)                                                 .02         0.94 (0.87-1.03)                                               .21
  With minimal exertion                                                           1.30 (1.23-1.37)                                                 \<.001      0.95 (0.86-1.04)                                               .02
  At rest (during day or night)                                                   1.53 (1.42-1.66)                                                 \<.001      0.87 (0.78-0.99)                                               .03
  Frequency of pain interfering with activity                                                                                                                                                                                 
  No pain                                                                         1 \[Reference\]                                                              1 \[Reference\]                                                
  Sometimes                                                                       0.90 (0.86-0.95)                                                 \<.001      1.00 (0.92-1.08)                                               .94
  Often                                                                           0.90 (0.86-0.94)                                                 \<.001      0.98 (0.92-1.05)                                               .59
  Log likelihood                                                                  −45 212.91                                                                   −15 825.15                                                     
  Akaike information criterion                                                    90 537.81                                                                    31 762.31                                                      

Abbreviations: ADL, activities of daily living; IADL, instrumental ADLs; OR, odds ratio.

Patients with an "unknown or unclear" or missing response for overall health status were excluded from regression analyses (n = 168).

The initial home health care assessment identified several additional factors that were independently associated with an increased risk of 1-year mortality, including dependence in multiple ADLs/IADLs (OR, 2.80; 95% CI, 2.57-3.05; *P* \< .001), dyspnea at rest (OR, 1.53; 95% CI, 1.42-1.66; *P* \< .001), 2 or more hospitalizations in the past 12 months (OR, 1.21; 95% CI, 1.17-1.26; *P* \< .001), frailty (OR, 1.07; 95% CI, 1.03-1.11; *P* \< .001), living in an assisted living setting (OR, 1.21; 95% CI, 1.12-1.31; *P* \< .001), and an overall poor health status (OR, 2.21; 95% CI, 2.01-2.44; *P* \< .001).

Factors Independently Associated With Hospice Use {#H2-7-ZOI200006}
-------------------------------------------------

Several sociodemographic and clinical factors were independently associated with higher odds of receiving hospice care prior to death, including older age (≥75 years: OR, 1.23; 95% CI, 1.14-1.32; ≥85 years: OR, 1.49; 95% CI, 1.37-1.61; *P* \< .001), female sex (OR, 1.11; 95% CI, 1.05-1.17; *P* \< .001), and a cancer diagnosis (OR, 2.25; 95% CI, 2.11-2.41; *P* \< .001). Similar to the mortality model, the postdischarge initial home health assessment identified additional factors independently associated with increased odds of hospice use independent of patient-related and sepsis-related factors, including an overall poor health status (OR, 1.40; 95% CI, 1.19-1.65 *P* \< .001) and living with someone (OR, 1.16; 95% CI, 1.08-1.26; *P* \< .001) or in an assisted living setting (OR, 1.93; 95% CI, 1.69-2.19; *P* \< .001) ([Table 3](#zoi200006t3){ref-type="table"}). Of note, multiple factors were independently associated with significantly reduced odds of hospice use, including age younger than 65 years (OR, 0.76; 95% CI, 0.69-0.84; *P* \< .001), non-Hispanic white race (OR, 0.77; 95% CI, 0.72-0.82), being Medicaid-eligible (OR, 0.77; 95% CI, 0.72-0.82; *P* \< .001), noncancer comorbidities (chronic pulmonary disease, heart failure, diabetes, obesity, and peripheral vascular disease), ICU use (OR, 0.91; 95% CI, 0.86-0.96; *P* \< .001), or a bone/joint/skin/tissue infection source (OR, 0.78; 95% CI, 0.72-0.85; *P* \< .001) during the index sepsis stay.

Role of Cancer in Mortality and Hospice Use After Sepsis {#H2-8-ZOI200006}
--------------------------------------------------------

In this cohort, 11 427 (13.0%) sepsis survivors discharged to home health care services had a cancer diagnosis. Among them, older age (≥85 years: OR, 1.09; 95% CI, 0.95-1.23; *P* = .21) and the source and severity of sepsis were no longer significantly associated with 1-year mortality. Of note, dependence in multiple ADLs/IADLs (OR, 2.55; 95% CI, 2.01-3.23; *P* \< .001) and an overall poor health status (OR, 2.98; 95% CI, 2.33-3.80; *P* \< .001) after discharge remained independently associated. Among the 5965 (24.4%) decedents with cancer, age and sex were no longer associated with hospice use. Complete results from stratified analyses are given in eTables 3 and 4 in the [Supplement](#note-ZOI200006-1-s){ref-type="supplementary-material"}.

Discussion {#H1-4-ZOI200006}
==========

In this national cohort study, we examined risk factors for long-term mortality and patterns of end-of-life care among sepsis survivors who were Medicare beneficiaries and were discharged to home health care. More than one-quarter of patients died in the year following discharge, with most deaths occurring within 6 months. Two-thirds of the decedents were admitted to a hospital in the last 30 days of life where more than half received care in an ICU and 1 in 4 died. We also identified several patient-related, sepsis-related, and home health assessment factors associated with mortality and hospice use after sepsis survivorship.

The 1-year mortality rate among sepsis survivors in the present study is within the range previously reported in the literature.^[@zoi200006r9],[@zoi200006r16],[@zoi200006r36]^ Shankar-Hari et al^[@zoi200006r16]^ and Yende et al^[@zoi200006r36]^ recently reported 1-year mortality rates of 15% and 17.6%, respectively, among relatively young and previously healthy patients with few comorbidities and high rates of prehospital functional independence. In contrast, Prescott et al^[@zoi200006r9]^ found a 1-year mortality rate of 48.5% among sepsis survivors in the Health and Retirement Study cohort, which includes an older population with multiple comorbidities and at least some functional dependence at baseline. The most likely explanation for such a wide range in mortality rates is the variation in the populations studied. Although patterns over time in the risk of long-term mortality after sepsis have not been described, if the pattern follows the decline seen in acute sepsis mortality over the past decade,^[@zoi200006r2]^ the more contemporary data used in this study may further explain the lower mortality rate observed compared with that observed by Prescott et al.^[@zoi200006r9]^ Finally, the present study focused on the Medicare home health care population, which tends to be older and sicker and more likely to live below the federal poverty level compared with general Medicare beneficiaries.^[@zoi200006r37]^ However, whether and how much home health care is associated with long-term sepsis survivorship remains unknown and warrants further study.

The present study's results support previous reports of older age, male sex, medical admission type, comorbidities, and cancer in particular, being important risk factors for long-term mortality after sepsis.^[@zoi200006r16],[@zoi200006r38]^ Additional sepsis-related risk factors were identified, including severe sepsis, respiratory infection source, and ICU use. Such information may be useful to guide future efforts to develop and test risk stratification models among sepsis survivors, which may facilitate tailoring postdischarge care decisions. For example, the optimal intensity and timing of postacute care services^[@zoi200006r39]^ and follow-up with primary care clinicians^[@zoi200006r40]^ for sepsis survivors is unknown.

Several factors were identified on the home health care assessment after discharge that were associated with death within 1 year, independent of the foregoing patient-related and sepsis-related factors. Such factors included dyspnea at rest, 2 or more hospitalizations in the past 12 months, living in an assisted living setting, and an overall poor health status. In addition, similar to recent findings among Medicare sepsis survivors discharged to a skilled nursing facility,^[@zoi200006r41]^ dependence in multiple ADLs was an independent risk factor for mortality after sepsis in this home health care population. Moreover, we found a high prevalence of uncontrolled pain and dyspnea after discharge, 2 of the most common reasons for emergency department visits and readmissions among chronically ill patients.^[@zoi200006r42],[@zoi200006r43]^ These findings suggest that there is a unique opportunity for trained home health care clinicians to identify high-risk sepsis survivors and facilitate targeted interventions. For example, such patients may benefit from more frequent contact with their primary care or specialty clinicians, advance care planning, palliative care consultation, or even hospice referral in some cases. Patients referred to hospice from nonhospital sources are more likely to receive end-of-life care consistent with the preferences of most patients in the United States facing serious illness, including continuous home hospice care and dying at home.^[@zoi200006r29],[@zoi200006r44]^

Among the decedents in this cohort, we found that approximately two-thirds were admitted to the ICU in the last 30 days of life, which is a rate nearly 3 times that recently reported among all Medicare fee-for-service beneficiaries during a similar time frame.^[@zoi200006r45]^ Furthermore, ICU use during the index sepsis stay was associated with lower odds of subsequent hospice use prior to death despite being associated with significantly increased risk of mortality. Although this observational study could not determine causality, we believe that prior ICU use as a potential barrier to hospice enrollment is an important area for further exploration. It is possible that for patients who recently survived a sepsis hospitalization and often an ICU stay, patients, families, and clinicians alike may rely on that past performance to predict the future.^[@zoi200006r46]^ Such performance heuristics are common in medical decision-making, and often serve as a barrier to seeing the overall trajectory of functional decline that is common among patients with chronic illness.^[@zoi200006r47]^

Although the rate of hospice enrollment among the decedents in this home health sepsis cohort was similar to a recent report among a general Medicare fee-for-service population,^[@zoi200006r45]^ the median hospice length of stay in the present study was considerably shorter. This finding suggests a missed opportunity within home health care to improve end-of-life care, supported by the finding that the median time to hospice admission was 100 days from sepsis discharge. For example, patients with a diagnosis of heart failure, chronic pulmonary disease, or peripheral vascular disease in this cohort had considerably increased mortality risk, yet they were less likely to receive hospice care. Thus, earlier disease-specific interventions to improve end-of-life care in this population may be needed.

Limitations {#H2-9-ZOI200006}
-----------

This study has limitations. First, although this study offers an important first look at mortality risk and end-of-life care outcomes among sepsis survivors discharged to home health care, these results may not be generalizable to other sepsis populations, such as those discharged to home without home health care or those discharged to institutional postacute care. Prospective observational studies, designed to confirm whether functional and overall health status assessment are associated with mortality among sepsis survivors discharged to home, are needed. Second, given the inherent limitations of identifying sepsis survivors using administrative claims, future studies may benefit from sepsis identification from electronic clinical records in accordance with current international sepsis definitions.^[@zoi200006r48]^ Third, a comparison group of nonsepsis hospital discharges to home health care was not available to quantify how many of the present study's findings are directly attributable to sepsis vs other diagnoses with home health care. We were also unable to examine in this retrospective study whether the outcomes were mediated by types of home health care services received owing to unmeasurable indication bias. Prior studies have found mixed evidence for the efficacy of physical or occupational therapy after sepsis^[@zoi200006r49],[@zoi200006r50]^; consequently, pragmatic randomized trials are needed. In addition, we acknowledge that patient preferences regarding end-of-life care were unknown for this cohort such that it was not possible to assess whether hospitalization near the end of life or dying in the hospital reflected goal-concordant care in some cases.^[@zoi200006r51]^

Conclusions {#H1-5-ZOI200006}
===========

Improvements in sepsis care have led to an increase in short-term survival, yet long-term mortality rates after hospital discharge remain high. Many sepsis survivors have readily identifiable characteristics that are associated with an increased risk of death, which may help direct interventions that mitigate the high rates of aggressive and intensive care experienced near the end of life among this population. Further research is needed to understand the association of postacute care services with mortality risk and end-of-life outcomes among sepsis survivors.
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